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Purpose: An obesity clinic was newly opened at a single university hospital in South Korea. We aimed to characterize 
the profile of patients and current status of the clinic. Materials and Methods: 60 patients who have visited the obesity 
clinic from October 2015 to April 2016 were included in this study. Baseline examination included anthropometric 
measurement, bioelectrical impedance analysis, blood sampling, and abdominal computed tomography (CT) analysis to 
estimate abdominal fat distribution. Weight loss program of the clinic constituted of 8 sessions of physician encounter 
and nutrition counselling. Data on the profile of patients and their completion status were collected and analyzed. Results: 
Sixty obese adults (21 males and 39 females) were included in the study. The mean (±standard deviation [SD]) body mass 
index was 31.1±5.7, and abdominal circumference was 100.2±18.3. The mean±SD percentage of body fat measured by 
bioelectrical impedance analysis was analyzed 35.7±6.2% in males, and 40.6±6.2% in females. The average intra-abdominal 
fat area was 243.7 cc in males, and 142.5 cc in females. Among 60 subjects, 37 patients (61.7%) are currently on their 
sessions; 11 patients (18.3%) completed 8 sessions of the program; 8 patients (13.3%) dropped out; 4 patients (6.7%) 
did not register the program session with initial evaluation only. The mean weight loss (kg) of 11 completers was 5.1 
kg. Conclusion: Using the strengths of a university hospital as multidisciplinary team care, effective treatment strategies 
for overweight and obesity are the future directions of our clinic.
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INTRODUCTION 
The growing prevalence of obesity is a global health 
concern. According to WHO Adult Obesity Facts, more 
than one-third of U.S. adults are obese [1]. Obesity issues 
have been considered more prominent in western coun-
tries, but an increasing number of Asian countries are 
quickly gaining weight. Also in Korea, 31.5 percent of 
Korean adults were analyzed to be categorized as obese, 
with a BMI of 25 or above according to Korea National 
Health and Nutrition Examination Surveys (KNHANES) in 
2014. American Medical Association [2] has recently anno-
unced obesity as a disease. Obesity-related conditions 
include hypertension, dyslipidemia, type 2 diabetes, stroke, 
coronary heart disease, sleep apnea and certain types of 
cancer [3]. Growing prevalence of obesity and obesity-rel-
ated diseases leads to increasing socioeconomic burden. 
According to the National Health Insurance Corporation 
(NHIC) cohort data and the 2005 Korea National Health 
and Nutrition Examination Survey (KNHANES) data, the 
estimated total socioeconomic costs of overweight and 
obesity were approximately U$1,787 million (men: U$1,081 
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Table 1. General characteristics of patients visiting obesity clinic at one university medical center
Total Male Female P-value
n (%) 60 (100) 21 (35.0) 39 (65.0)
Age 40.2±13.9 41.0±14.5 39.8±13.8 0.002
  ≤19 2 (3.3) 0 2 (5.1) 0.39
  20-39 28 (46.7) 11 (52.4) 17 (43.6)
  40-59 22 (36.7) 5 (23.8) 17 (43.6)
  ≥60 8 (13.3) 5 (23.8) 3 (7.7)
Height (cm) 164.4±8.8 173.6±6.5 159.4±5.1 0.06
Weight (kg) 84.9±21.2 101.4±22.1 76.1±14.6 0.04
BMI (kg/m2) 31.1±5.7 33.4±6.0 29.8±5.2 0.07
  <25 9 (15.0) 2 (9.5) 7 (17.9) 0.07
  ≥25, <30 21 (35.0) 6 (28.6) 15 (38.5)
  ≥30, <35 16 (26.7) 5 (23.8) 11 (28.2)
  ≥35 14 (23.3) 8 (38.1) 6 (15.4)
Waist circumference (cm) 100.2±18.3 112.7±13.1 93.3±17.3 0.15
Hip circumference (cm) 108.7±6.8 112.3±6.3 107.0±6.4 0.08
SBP (mmHg) 131.9±22.6 138.6±18.9 126.9±23.7 0.02
DBP (mmHg) 82.3±14.9 88.2±12.7 79.0±15.2 0.06
Muscle (kg)† 28.3±7.2 36.3±5.7 24.1±3.2 0.06
Fat (kg)† 33.8±12.0 37.3±14.1 32.0±10.5 0.07
Fat percent (%)† 38.9±6.6 35.7±6.2 40.6±6.2 0.03
Abdominal total fat area (cc)‡ 465.2±163.9 553.3±192.7 414.9±121.5 0.13
Abdominal visceral fat area (cc)‡ 179.3±86.6 243.7±91.6 142.5±58.2 0.13
Abdominal subcutaneous fat area (cc)‡ 285.8±112.9 309.5±137.9 272.3±95.4 0.22
Data are presented as n (%) or Mean±SD.
†measured by bioelectrical impedance analysis.
‡measured by abdominal computed tomography (CT).
million, women: U$706 million) [4]. 
The early detection and appropriate management of 
obesity are needed to reduce the burden of obesity related 
diseases. AHA/ACC/TOS has provided an algorithm for 
primary care physicians in the evaluation, prevention, and 
management of excess body weight in their patients [5]. 
Treatment options include lifestyle modifications, such as 
dietary, physical activity, and behavioral intervention, and 
medical interventions, such as pharmacotherapy and 
surgery. Since obesity is a multifactorial disease, manage-
ment of obesity is needed to be coordinated among multi-
disciplinary treatment teams. University medical center 
has its strength in multidisciplinary care compared with 
primary care setting. Evaluation and management of obesity 
can be more individualized to obese patients.
Herein, we report an example of the obesity clinic newly 
opened at a single university hospital in South Korea. We 
aimed to characterize the profile of patients visiting our 
clinic and discuss the challenges and future directions of 
our clinic.
MATERIALS AND METHODS
In this study, we included 60 patients who have visited 
the obesity clinic from October 2015 to April 2016. Base-
line examination of obesity clinic included anthropometric 
measurements obtained by a trained and certified nurse. 
The height (cm), weight (kg), waist circumference (cm), 
and hip circumference (cm) of each subject were measured, 
and the body mass index (BMI; kg/m2) was calculated as 
body weight (kilogram) divided by body height squared 
(square meter). Overweight was defined as a BMI of 23.0 
kg/m2 or greater, and obesity was defined as a BMI of 25.0 
kg/m2 or greater according to WHO definitions based on the 
revised criteria for Asian populations [6]. Bioelectrical im-
pedance (BIA) measurement, evaluating exercising capacity, 
and analyzing abdominal computed tomography (CT) 
measurements to estimate abdominal fat distribution were 
done to each patient. Fasting venous blood samples were 
drawn into serum separator tubes from all subjects on their 
first visit. Complete blood count, serum glucose, hemoglobin 
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Table 2. Biochemical profiles of patients visiting obesity clinic at one university medical center
Total Male Female P-value
Fasting glucose, mg/dl 109.5±40.5 126.9±61.4 99.7±15.6 0.73
Hemoglobin A1c, % 6.0±1.4 6.5±2.1 5.7±0.7 0.62
Total cholesterol, mg/dl 210.4±32.9 206.9±27.8 212.4±35.8 0.49
HDL, mg/dl 50.5±12.8 45.3±8.4 53.3±14.0 0.004
LDL, mg/dl 130.7±31.5 131.5±29.8 130.3±32.9 0.19
Triglyceride, mg/dl 137.0±76.2 151.6±82.2 129.0±72.8 0.02
Creatinine, mg/dl 0.78±0.16 0.95±0.14 0.69±0.08 0.16
eGFR 102.8±16.1 98.4±18.4 105.3±14.3 0.02
ALP, IU/L 57.3±15.6 57.9±20.3 56.9±12.5 0.36
AST, U/L 36.5±36.8 50.2±50.6 28.6±23.4 0.37
ALT, U/L 51.5±47.4 78.0±56.4 36.1±33.6 0.15
TSH, uIU/ml 2.3±2.4 2.3±1.1 2.3±2.9 0.46
Urine albumin/creatinine ratio, mg/g.Cre 22.6±42.1 32.28±63.3 16.3±18.0 0.29
Table 3. Completion status of total patients (based on May 2016) 
Status Total Male Female P-value
On session 37 (61.7) 10 (47.6) 27 (69.2) 0.32
Completed 11 (18.3) 6 (28.6) 5 (12.8)
Not registered (only
initial evaluation done)
4 (6.7) 2 (9.5) 2 (5.1)
Dropout 8 (13.3) 3 (14.3) 5 (12.8)
Total 60 (100) 21 (100) 39 (100)
A1C, ALP (alkaline phosphatase), AST (aspartate aminotran-
sferase), ALT (alanine aminotransferase), albumin, total 
protein, calcium, phosphorus, total cholesterol, triglyceride, 
HDL (high density lipoprotein), LDL (low density lipoprotein), 
thyroid stimulating hormone (TSH), and free T4 were 
measured. 
Patients were told the result of baseline measurement by 
a physician in a week after initial visit day, and registered 
the obesity management program. The program cons-
tituted of 8 sessions following the initial visit and patients 
were recommended to complete the course within three 
months. During the first month, the patient was supposed 
to visit the clinic every one week, and then visit every two 
weeks during the next two months. Patients were encou-
raged to keep a food diary daily in written form. Each 
session was made of anthropometric measurement, BIA 
analysis, physician encounter and nutrition counseling by a 
nutritionist. After the 8 sessions, some completers have 
re-registered the program of 8 sessions, and the others 
were recommended a short-term visit to the clinic.
We analyzed the characteristics of sixty patients by t-test 
for continuous variable and chi-square test for categorical 
variables. Regarding the patient who had completed the 
program, we compared the result of the initial evaluation 
with that of the last session. All analyses were conducted 
using SPSS, version 21.0 (SPSS Inc., Chicago, IL).
RESULTS
Sixty obese adults (21 males and 39 females) were included 
in the study. The mean (±standard deviation [SD]) age was 
39.5±12.7 years. The rates for those in the age group of ≤
19 years, 20-39 years, 40 to 59 years, and ≥60 years were 
3.3%, 46.7%, 36.7%, and 13.3%, respectively (P=.39). The 
mean±SD BMI was 31.1±5.7, and AC was 100.2±18.3. 
The mean±SD percentage of fat measured by bioelectrical 
impedance analysis was analyzed 35.7±6.2% in males, and 
40.6±6.2% in females (P=.03). The mean±SD area of 
abdominal visceral fat area was 243.7±91.6 (cc) in males, 
and 142.5±58.2 (cc) in females (P=.13). General characte-
ristics and biochemical profiles of patients are shown in 
Table 1 and 2. 
As shown in Table 3, among study subjects 37 patients 
(61.7%) are currently on their sessions based on May 2016; 
11 patients (18.3%) completed 8 sessions; 8 patients (13.3%) 
dropped out; 4 patients (6.7 %) did not register the program 
session with initial evaluation only (P=.32).
Table 4 compares the result of initial assessment with the 
result of the last session among 11 patients at the end of 8 
sessions. The mean weight loss kilogram of 11 patients was 
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Table 4. Comparison between the result of initial assessment with the result of the last session (n=11)
Case Sex Age Height BMI
Initial Session 8
△Wt (kg) △AC (cm)
Wt AC Wt AC
1 F 20 157.1 36.1 89 94 87.1 90.5 1.9 3.5
2 M 44 178.6 28.6 91.3 99 78.8 91.5 12.5 7.5
3 M 40 173.3 37.7 113.3 112 105.4 106 7.9 6
4 M 29 181 41.5 136 133 128.2 126.5 7.8 6.5
5 F 63 156.9 24.4 60.1 80.5 59.5 80 0.6 0.5
6 F 33 173.6 35.7 106.7 110 105.5 105.5 1.2 4.5
7 M 31 175.9 37.4 115.8 112.5 110.1 107 5.7 5.5
8 F 49 157 31.2 77 104.5 71.5 95.5 5.5 9
9 M 69 157.4 29.1 72.1 99 67.8 95 4.3 4
10 M 28 180.3 44.5 144.8 135.5 139.2 131 5.6 4.5
11 F 41 155 32.1 77.1 90 74.3 90 2.8 0
5.1 kg. Subjects who did not lose their weight enough 
despite 8 sessions were to re-register the program or do 
regular follow-ups.
DISCUSSION
Patient-centered programs as well as individual effort to 
lose weight are both important for obesity management. 
Multidisciplinary care and practical approaches to lifestyle 
change can be an effective means of treatment for many 
patients. Diet, exercise and behavior modification are the 
foundation of managing obesity. Pharmacologic or surgical 
treatment of obesity can also be considered. The physician 
must consider the patient’s risk status when selecting 
appropriate therapy for obesity. In some persons surgical 
intervention may be considered if medical treatment and 
lifestyle modification are insufficient. In terms of surgical 
management of obesity, the Asian perspective on bariatric 
and metabolic surgeries has not been actively discussed 
until recently, despite an elevated risk of type 2 diabetes 
mellitus, hypertension, and hyperlipidemia at a relatively 
lower BMI than Western populations [7]. In our clinic, sixty 
subjects were all intervened with medical management. 
Several patients whose weight loss was crucial due to 
coexisting conditions were recommended surgical treatment 
by physicians. Although diet, exercise and lifestyle modifi-
cations remain the cornerstones of obesity treatment, 
bariatric surgery should be considered the treatment of 
choice for morbidly obese patients.
The mean weight loss kilogram of 11 patients who had 
completed the program in our clinic was 5.1 kg. Success in 
maintaining weight loss can be defined as intentionally 
losing 5-10% of initial body weight and maintaining it for at 
least one year. According to this definition, long-term result 
of these patients would be necessary with appropriate 
follow-up strategies. Identifying the predictors of drop-out 
can be also helpful to discuss the challenges and future 
directions of our clinic. 
In this study, we reported an example of the newly 
opened obesity clinic at a single university hospital in 
South Korea. Effective treatment strategies for overweight 
and obesity would be implemented using the strengths of a 
university hospital as multidisciplinary team care in the 
future. 
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